Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1-specific ligand

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 10, 2007, Pages 4785-4794

  Dun, Ying ^a   Thangaraju, Muthusamy ^a   Prasad, Puttur ^a   Ganapathy, Vadivel ^a   Smith, Sylvia B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITOTOXIN; PENTAZOCINE; SIGMA OPIATE RECEPTOR; GLUTAMIC ACID; HOMOCYSTEINE; LIGAND; MESSENGER RNA; NARCOTIC ANTAGONIST; NEUROPROTECTIVE AGENT; SIGMA 1 OPIATE RECEPTOR; SIGMA-1 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; EXCITOTOXICITY; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA; RETINA GANGLION CELL; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL SURVIVAL; DRUG EFFECT; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; METABOLISM; NEWBORN; PHASE CONTRAST MICROSCOPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; CELLS, CULTURED; GLUTAMIC ACID; HOMOCYSTEINE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LIGANDS; MICE; MICE, INBRED C57BL; MICROSCOPY, INTERFERENCE; NARCOTIC ANTAGONISTS; NEUROPROTECTIVE AGENTS; PENTAZOCINE; RECEPTORS, SIGMA; RETINAL GANGLION CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 35748936457     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0343     Document Type: Article

References (44)

1. Hayashi T, Su TP. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs. 2004;18:269-284.
2. Quirion R, Bowen WD, Itzhak JL, et al. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci. 1992;13:85-86.
3. Hanner M, Moebius FF, Flandorfer A, et al. Purification, molecular cloning, and expression of the mammalian sigma 1-binding site. Proc Natl Acad Sci USA. 1996;93:8072-8077.
4. Kekuda R, Prasad PD, Fei YJ, et al. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun. 1996;229:553-558.
5. Prasad PD, Li HW, Fei YJ, et al. Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 sigma receptor gene. J Neurochem. 1998;70:443-451.
6. Seth P, Leibach FH, Ganapathy V. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem Biophys Res Commun. 1997;241:535-540.
7. Seth P, Fei YJ, Li HW, et al. Cloning and functional characterization σ from rat brain. J Neurochem. 1998;70:922-931.
8. Yamamoto H, Yamamoto T, Sagi N, et al. Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via sigma 1 site. J Neurosci. 1995;15:731-736.
9. Bhardwaj A, Sawada M, London ED, et al. Potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates basal and N-methyl-D- aspartate-evoked nitric oxide production in vivo. Stroke. 1998;29:2404-2411.
10. Klette KL, DeCoster MA, Moreton JE, et al. Role of calcium in sigma-mediated neuroprotection in rat primary cortical cultures. Brain Res. 1995;704:31-41.
11. Katnik C, Guerrero WR, Pennypacker KR, et al. Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia. J Pharmacol Exp Ther. 2006;319:1355-1365.
12. Lobner D, Lipton P. σ-Ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia. Neurosci Lett. 1990;117:169-174.
13. Lockhart BP, Soulard P, Benicourt C, et al. Distinct neuroprotective profiles for σ-ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 1995;675:110-120.
14. Vagnerova K, Hurn PD, Bhardwaj A, et al. Sigma 1 receptor agonists act as neuroprotective drugs through inhibition of inducible nitric oxide synthase. Anesth Analg. 2006;103:430-434.
15. Schoenwald RD, Barfknecht CR, Xia E, et al. The presence of σ receptor in the lacrimal gland. J Ocular Pharmacol. 1993;9:125-139.
16. Bucolo C, Campana C, Di Toro R, et al. Sigma 1 recognition sites in rabbit iris-ciliary body: topical sigma 1-site ligands lower intraocular pressure. J Pharmacol Exp Ther. 1999;289:1362-1369.
17. Ola MS, Moore PM, El-Sherbeny A, et al. Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina. Mol Brain Res. 2001;95:86-95.
18. Wang L, Duncan G. Silencing of sigma-1 receptor induces cell death in human lens cells. Exp Cell Res. 2006;312:1439-1446.
19. Senda T, Matsuno K, Mita S. The presence of sigma receptor subtypes in bovine retinal membranes. Exp Eye Res. 1997;64:857-860.
20. Ola MS, Martin PM, Maddox D, et al. Analysis of sigma receptor (σR1) expression in retinal ganglion cells cultured under hyperglycemic conditions and in diabetic mice. Brain Res Mol Brain Res. 2002;107:97-107.
21. Jiang G, Mysona B, Dun Y, et al. Expression, subcellular localization and regulation of sigma receptor in retinal Müller cells. Invest Ophthamol Vis Sci. 2006;47:5576-558.
22. Gardner TW, Antonetti DA, Barber AJ, et al. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol. 2002;47(suppl 2):S253-S262.
23. Levin LA, Gordon LK. Retinal ganglion cell disorders: types and treatments. Prog Retin Eye Res. 2002;21:465-484.
24. de Costa BR, Bowen WD, Hellewell SB, et al. Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors. FEBS Lett. 1989;251:53-58.
25. Martin PM, Ola MS, Agarwal N, et al. The sigma receptor (σR) Iigand (+)-pentazocine prevents retinal ganglion cell death induced in vitro by homocysteine and glutamate. Brain Res Mol Brain Res. 2004;123:66-75.
26. Moore P, El-Sherbeny A, Roon P, et al. Apoptotic retinal ganglion cell death is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res. 2001;73:45-57.
27. -) exchanger in cultured retinal ganglion cells and regulation by nitric oxide and oxidative stress. Cell Tiss Res. 2006;324:189-202.
28. Selhub J, Bagley LC, Miller J, et al. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr. 2000;71(suppl):614S-620S.
29. Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ. 2004;(suppl 1):S56-S64.
30. Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 2003;26:137-146.
31. Heuberger RA, Fisher AI, Jacques PF, et al. Relation of blood homocysteine and its nutritional determinants to age-related maculopathy in the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 2002;76:897-902.
32. Axer-Siegel R, Bouria D, Ehrlich R, et al. Association of neovascular age-related macular degeneration and hyperhomocysteinemia. Am J Ophthalmol. 2004;137:84-89.
33. Weger M, Stanger O, Deutschmann H, et al. Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmolmology. 2002;109:1105-1109.
34. Bleich S, Junemann A, von Ahsen N, et al. Homocysteine and risk of open-angle glaucoma. J Neural Transnt. 2002;109:1499-1504.
35. Bleich S, Roedl J, Von Ahsen N, et al. Elevated homocysteine levels in aqueous humor of patients with Pseudoexfoliation glaucoma. Am J Ophthalmol. 2004;138:162-164.
36. Yang G, Lu J, Pan C. The impact of plasma homocysteine level on development of retinopathy in type 2 diabetes mellitus. Zhonghua Net Ke Za Zhi. 2002;41:34-38.
37. Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol. 2003;136:1136-1150.
38. Seddon JM, Gensler G, Klein ML, et al. Evaluation of plasma homocysteine and risk of age-related macular degeneration. Am J Ophthalmol. 2006;141:201-203.
39. Wang NC, Lai CC, Chen TL, et al. Branch retinal artery occlusion in a young man with hyperhomocysteinemia. Retina. 2005;25:940-942.
40. Poloschek CM, Fowler B, Unsold R, et al. Disturbed visual system function in methionine synthase deficiency. Graefe's Arch Ophthalmol. 2005;243:497-500.
41. Trotti D, Rossi D, Gjesdal O, et al. Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem. 1996;271:5976-5979.
42. Ramachandran S, Lu H, Prabhu U, Ruoho AE. Purification and characterization of the guinea pig sigma-1 receptor functionally expressed in Escherichia coli. Protein Expr Purif. 2007;51:283-392.
43. 3H] dopamine release is dependent upon protein kinase C. J Pharmacol Exp Ther. 2003;304364-369.
44. Hayashi T, Su TP. Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells. J Pharmacol Exp Ther. 2003;306:726-733.